Dengue Virus Serotype 4, Roraima State, Brazil
To the Editor: In July 2010, dengue virus serotype 4 (DENV-4) reemerged in Boa Vista, the capital of Roraima State, in northern Brazil ( Figure, panel A) , after an absence of 28 years (1) . Cases were identifi ed during late June in the municipalities of Boa Vista and Cantá. For all patients, the clinical course of disease was classic, and all recovered uneventfully. The most commonly reported signs and symptoms were fever, headache, chills, muscle and joint pains, rash, nausea and vomiting, and retro-ocular pain. Patient ages were 11-51 years (median 31 years); 5 patients were male. Because of the clinical picture, dengue was suspected, and serum samples were collected and sent to Instituto Evandro Chagas for virus isolation. Of 10 DENV strains recovered, 9 were isolated into C6/36 cell samples as described elsewhere (2) . Cytopathic effects were observed on days 5-7 postinfection, and virus isolation was confi rmed by use of indirect immunofl uorescent assay (3). Molecular approaches led to diagnosis of 10 cases. Viral RNA was recovered from infected cells in the supernatant by using a QIAquick viral RNA extraction kit (QIAGEN, Valencia, CA, USA); genome amplifi cation was performed by using a 1-step reverse transcription-PCR (RT-PCR) (4) and 2 set of oligonucleotides designed to amplify the entire N gene in overlapping PCR products. PCR amplifi cation was performed on 5 DENV strains, and the envelope gene (1,425 bp) was completely sequenced by the dideoxinucleotide terminator method for 3 strains (5) by using the same set of oligonucleotides as for the RT-PCR amplifi cation.
Phylogenetic analysis was performed by using the neighbor-joining method (6) and homologous sequences of different DENV-4 strains isolated in Central and South America (7, 8) . The Asian genotype II strains (Thailand 1978-U18441 and Thailand 1985-AY780644) were used as outgroups to give confi dence to phylogenetic groupings.
Phylogenetically, the DENV-4 strains grouped in genotype I and clustered with Venezuelan strains isolated from 2004 through 2007 (Brazil/Venezuela group) and were distantly related to strains isolated in Venezuela from 1998 through 2000. This result indicates that the current DENV-4 strains isolated in Roraima State were reintroduced to Brazil through Venezuela, where DENV-4 has circulated since the 1980s (1). This result also excludes the possibility that Asian genotypes previously circulated in Brazil. The DENV-4 strains isolated from patients in Roraima State in 2010 were genetically distinct from DENV-4 strains isolated in the 1980s (Figure,  panel B) .
During the 2010 outbreak, cocirculation of DENV-1 and DENV-2 in addition to DENV-4 was demonstrated by virus isolation (68 strains) and RT-PCR amplifi cation (genome detection in 39 strains). The municipality of Boa Vista, which has ≈266,901 inhabitants, reported 5,243 dengue cases (3,936 dengue fever, 259 severe dengue or dengue hemorrhagic fever) in 2010 (epidemiologic week 37), many of them diagnosed by serologic testing (9) . These numbers represent an increase of 154% over the 2,066 cases reported in 2009 (10).
DENV-4 had been introduced to Brazil through Boa Vista before the reemergence reported here; in 1982, DENV-1 and DENV-4 were described in Brazil, and a serologic survey estimated 11,000 dengue infections (1) . After that outbreak, DENV-4 was eradicated and not again detected until the episode reported here. To monitor the circulation of DENV-4 in Roraima and other Brazilian states through the present date (epidemiologic week 48), strong serologic and virologic surveillance have been conducted; cases of this serotype have not been recognized outside Roraima State. As a preventive measure in Boa Vista, a total of 10,358 dwellings were visited and 18,305 larval Aedes aegypti mosquito foci were eliminated by spraying of mosquito adulticide. Nonetheless, as summer approaches in Brazil, a heavy rainy season is expected, and DENV-4 is a candidate to become a serious threat in the country. Therefore, the Ministry of Health has prepared a plan to investigate DENV-4 circulation; it calls for early detection of disease and adoption of control measures to avoid or minimize spread of this dengue serotype throughout the country.
Novel Phlebovirus in Febrile Child, Greece
To the Editor: Phleboviruses (family Bunyaviridae, genus Phlebovirus) are arthropod-borne, single-stranded, RNA viruses. Their genome consists of 3 segments-small, medium, and large-which encode the nucleoprotein and nonstructural proteins, the envelope glycoproteins, and the viral polymerase, respectively (1). The genus Phlebovirus consists at least 60 antigenically distinct serotypes, including the sandfl y fever viruses transmitted to humans by phlebotomine sandfl ies. In the Mediterranean region, 3 phleboviruses are known to circulate: Toscana virus, sandfl y fever Naples virus, and sandfl y fever Sicilian virus. Sandfl y fever Naples virus and sandfl y fever Sicilian virus cause a transient febrile illness, whereas Toscana virus is sometimes neurovirulent, leading to aseptic meningitis and meningoencephalitis (2, 3) .
Phleboviruses have been detected in Greece in clinically ill persons and in sandfl ies; seroprevalance in humans is high, especially in the Ionian islands (3-7). In addition, in 2002, a Sicilian-like virus (Cyprus virus) was responsible for a major outbreak of febrile illness among Greek Army forces in Cyprus (8) . We report genetic detection and sequencing of an Adria virus from a boy who was hospitalized because of simple febrile seizure; the identical sequence was initially detected in sandfl ies collected in a coastal area in Albania.
On September 23, 2009, a 2.5-year-old boy was admitted to the Hippokration Hospital of Thessaloniki, Greece, after a single episode of simple febrile seizure. The patient was febrile (38.2°C) and had vomited 1 time while in nursery school. He had sudden onset of eye gaze, perioral cyanosis, masseter muscle spasm, generalized tonic convulsions of the body and extremities, and involuntary loss of urine. The episode lasted ≈3 minutes, after which the child became irritable and sleepy.
At the time of hospital admission (30 minutes later), he was afebrile and conscious. The boy's history contained no previous neurologic or developmental disabilities and no family history of epilepsy or febrile seizures.
Clinical examination, which included a thorough general and detailed neurologic evaluation, revealed no abnormalities except mild rhinitis. Laboratory tests showed leukocytosis (22,600 cells/μL) with 85.7% neutrophils. Blood levels of electrolytes, urea nitrogen, creatinine, glucose, albumin, bilirubin, alkaline phosphatase, and aminotransferases; prothrombin time; and urinalysis results were within reference limits. Electroencephalogram showed no brain abnormalities. Lumbar puncture and neuroimaging were not considered necessary.
After 2 days of hospitalization, the child recovered, was free of signs and symptoms, and was discharged from the hospital with a diagnosis of simple febrile seizure and mild upper respiratory infection. According to a report from his mother 1 year later, the child remains well without any recurrence of febrile or other type of seizures.
Viral RNA was extracted from the patient's blood sample taken at the time of hospital admission. 
